BioSpace News Archive

Saama Technologies, LLC. (“Saama”) today announced a multi-year agreement with Merck, known as MSD outside the United States and Canada, to build and operationalize a new clinical data layer leveraging Saama’s Life Science Analytics Cloud (LSAC) to strengthen Merck’s clinical development capabilities and expedite pipeline progress.

SAB Biotherapeutics today reported financial results for the second quarter ended June 30, 2022 and provided a company update.

A new study, published in The Lancet Global Health, finds the typhoid conjugate vaccine, Typbar TCV®, provides immunity for up to three years in children as young as nine months old in Malawi.

Psilera Inc. (“Psilera”), a biopharmaceutical company optimizing next-generation mental health treatments with a technology-enabled platform, announces promising results on two patent-pending N,N-dimethyltryptamine (“DMT”) analogues, PSIL-001 and PSIL-002.

Captura Biopharma, Inc. is developing oral chelators for the treatment of internal transuranic radionuclide contamination and heavy metal poisoning.

Versant Ventures today announced the debut of Vector BioPharma AG, a biopharmaceutical company developing a precision gene delivery platform that is devoid of viral genes.

Ocular Therapeutix, Inc. today announced that it will present at the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference on Wednesday, August 17, 2022.

Prellis Biologics, Inc (Prellis Bio), a biotherapeutics company, today appointed Michael Nohaile, PhD as its new CEO and announced it has raised a $35 million Series C funding round.

Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the first quarter of fiscal year 2023, ended June 30, 2022.

Lexaria Bioscience Corp. is pleased to announce that it has received a positive full written response from the Food and Drug Administration from its pre-Investigational New Drug (“Pre-IND”) meeting regarding DehydraTECH-CBD for the treatment of hypertension.